Prospector Partners LLC
- SEC CIK
- 0001080380
- Latest filing
- Feb 13, 2026
PPLT holding history
abrdn Platinum ETF Trust in every 13F filed by Prospector Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PPLT overviewAll 13F holders of PPLTFull Q4 2025 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −87,755−100.0% | Sold out | Holders |
| Q3 2025 | 87,755 | $12.5M | 1.5% | −2,914−3.2% | Reduced | Holders |
| Q2 2025 | 90,669 | $11.1M | 1.3% | −3,305−3.5% | Reduced | Holders |
| Q1 2025 | 93,974 | $8.59M | 1.0% | −416−0.4% | Reduced | Holders |
| Q4 2024 | 94,390 | $7.84M | 0.9% | +457+0.5% | Added | Holders |
| Q3 2024 | 93,933 | $8.44M | 0.9% | +1,758+1.9% | Added | Holders |
| Q2 2024 | 92,175 | $8.43M | 1.0% | +520+0.6% | Added | Holders |
| Q1 2024 | 91,655 | $7.66M | 0.9% | +1,410+1.6% | Added | Holders |
| Q4 2023 | 90,245 | $8.23M | 1.0% | +6,590+7.9% | Added | Holders |
| Q3 2023 | 83,655 | $7.00M | 1.0% | +250+0.3% | Added | Holders |
| Q2 2023 | 83,405 | $6.98M | 1.0% | +7,450+9.8% | Added | Holders |
| Q1 2023 | 75,955 | $6.98M | 1.0% | +195+0.3% | Added | Holders |
| Q4 2022 | 75,760 | $7.52M | 1.0% | 00.0% | Unchanged | Holders |
| Q3 2022 | 75,760 | $6.05M | 0.9% | −47,515−38.5% | Reduced | Holders |
| Q2 2022 | 123,275 | $10.2M | 1.5% | +725+0.6% | Added | Holders |
| Q1 2022 | 122,550 | $11.2M | 1.4% | +6,050+5.2% | Added | Holders |
| Q4 2021 | 116,500 | $10.5M | 1.2% | −1,200−1.0% | Reduced | Holders |
| Q3 2021 | 117,700 | $10.6M | 1.4% | −2,150−1.8% | Reduced | Holders |
| Q2 2021 | 119,850 | $12.0M | 1.5% | +1,150+1.0% | Added | Holders |
| Q1 2021 | 118,700 | $13.2M | 1.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.